These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 15820325)
21. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment]. Lecardeur L; Meunier-Cussac S; Dollfus S Encephale; 2013 May; 39 Suppl 1():S64-71. PubMed ID: 23528322 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of spontaneous movement disorders (dyskinesia, parkinsonism, akathisia and dystonia) in never-treated patients with chronic and first-episode psychosis: a systematic review and meta-analysis. Kalniunas A; James K; Pappa S BMJ Ment Health; 2024 Sep; 27(1):. PubMed ID: 39313255 [TBL] [Abstract][Full Text] [Related]
24. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients]. Langlois-Thery S; Dollfus S; Lesieur P; Petit M Encephale; 1994; 20(5):487-93. PubMed ID: 7828511 [TBL] [Abstract][Full Text] [Related]
25. Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients. Caligiuri MP; Lohr JB J Neuropsychiatry Clin Neurosci; 1997; 9(4):562-7. PubMed ID: 9447497 [TBL] [Abstract][Full Text] [Related]
26. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients. Ghadirian AM; Annable L; Bélanger MC; Chouinard G J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543 [TBL] [Abstract][Full Text] [Related]
27. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
29. Parkinsonism in neuroleptic-naive schizophrenic patients. Caligiuri MP; Lohr JB; Jeste DV Am J Psychiatry; 1993 Sep; 150(9):1343-8. PubMed ID: 8352344 [TBL] [Abstract][Full Text] [Related]
30. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856 [TBL] [Abstract][Full Text] [Related]
31. "Positive" and "negative" movement disorders in schizophrenia. Sandyk R; Kay SR Int J Neurosci; 1992 Oct; 66(3-4):143-51. PubMed ID: 1305614 [TBL] [Abstract][Full Text] [Related]
32. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G; Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797 [TBL] [Abstract][Full Text] [Related]
33. Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Rund BR; Melle I; Friis S; Larsen TK; Midbøe LJ; Opjordsmoen S; Simonsen E; Vaglum P; McGlashan T Am J Psychiatry; 2004 Mar; 161(3):466-72. PubMed ID: 14992972 [TBL] [Abstract][Full Text] [Related]
34. Patterns of symptoms in neuroleptic-naive patients with schizophrenia and related psychotic disorders before and after treatment. Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF Psychiatry Res; 2001 Dec; 105(1-2):97-105. PubMed ID: 11740979 [TBL] [Abstract][Full Text] [Related]
35. Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status. Putzhammer A; Perfahl M; Pfeiff L; Hajak G Pharmacopsychiatry; 2005 May; 38(3):132-8. PubMed ID: 15902585 [TBL] [Abstract][Full Text] [Related]
36. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia. Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344 [TBL] [Abstract][Full Text] [Related]
37. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309 [TBL] [Abstract][Full Text] [Related]
38. Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study. Chang WC; Hui CL; Tang JY; Wong GH; Chan SK; Lee EH; Chen EY Psychol Med; 2013 Sep; 43(9):1883-93. PubMed ID: 23217676 [TBL] [Abstract][Full Text] [Related]
39. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness. Honer WG; Kopala LC; Rabinowitz J J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513 [TBL] [Abstract][Full Text] [Related]